Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Current Assets (2018 - 2025)

Historic Current Assets for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $52.6 million.

  • Exagen's Current Assets rose 4790.06% to $52.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.6 million, marking a year-over-year increase of 4790.06%. This contributed to the annual value of $36.5 million for FY2024, which is 2379.97% down from last year.
  • Latest data reveals that Exagen reported Current Assets of $52.6 million as of Q3 2025, which was up 4790.06% from $51.0 million recorded in Q2 2025.
  • Exagen's 5-year Current Assets high stood at $129.4 million for Q1 2021, and its period low was $32.5 million during Q1 2025.
  • Moreover, its 5-year median value for Current Assets was $52.6 million (2025), whereas its average is $70.3 million.
  • As far as peak fluctuations go, Exagen's Current Assets skyrocketed by 6951.12% in 2021, and later crashed by 4184.59% in 2023.
  • Exagen's Current Assets (Quarter) stood at $112.7 million in 2021, then crashed by 35.59% to $72.6 million in 2022, then plummeted by 34.11% to $47.8 million in 2023, then fell by 23.8% to $36.5 million in 2024, then surged by 44.26% to $52.6 million in 2025.
  • Its last three reported values are $52.6 million in Q3 2025, $51.0 million for Q2 2025, and $32.5 million during Q1 2025.